Your session is about to expire
← Back to Search
Skills-Based Training
Caregiver Training Program Implementation for Enhancing Veteran Care
N/A
Waitlist Available
Led By Kelli Dominick Allen, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months (cumulative)
Awards & highlights
Study Summary
This trial aims to compare implementation strategies for large-scale spread of Caregivers FIRST, a group training for friend or family caregivers of Veterans. The goal is to use a type III effectiveness-implementation hybrid design framework to compare continuation of implementation strategies for 24 sites that do not meet implementation adoption benchmarks.
Who is the study for?
This trial is for sites that haven't met adoption benchmarks for a caregiver training program called Caregivers FIRST. These sites must agree to participate and will be randomly chosen to receive either standard or enhanced support to implement the training.Check my eligibility
What is being tested?
The study compares two methods of implementing the Caregivers FIRST program across various locations: Foundational REP (standard support) versus Enhanced REP (intensive support). It aims to see which strategy is more effective in spreading this caregiver training.See study design
What are the potential side effects?
Since this trial involves implementation strategies rather than medical treatments, it does not have traditional side effects. However, there may be differences in how well each site can adopt the program based on the strategy they receive.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months (cumulative)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months (cumulative)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Penetration
Secondary outcome measures
Adoption
Fidelity
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced REPExperimental Treatment1 Intervention
Enhanced REP begins with the same activities as Foundational REP. Sites randomized to receive Enhanced REP will continue with Foundational REP and also receive higher intensity support for a period of approximately 4 months. The higher intensity support will consist of facilitation, a process of interactive problem solving and support that occurs in a context of a supportive interpersonal relationship and CONNECT, a complexity science-based bundle of interaction-oriented activities designed to supplement implementation efforts by promoting team function and readiness for change. Facilitation will be provided by Function QUERI team members.
Group II: Foundational REPActive Control1 Intervention
Foundational REP uses the Replicating Effective Program implementation strategy and includes 5 elements that were developed and tested in the investigators' prior Function QUERI work: Stakeholder engagement; Toolkit; SharePoint access for clinical program training materials; Data dashboard to assist sites with tracking their own data; and Diffusion Networks to promote peer-to-peer sharing and implementation support.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,578 Total Patients Enrolled
Kelli Dominick Allen, PhDPrincipal InvestigatorDurham VA Medical Center, Durham, NC
9 Previous Clinical Trials
1,640 Total Patients Enrolled
Susan N. Hastings, MD MHScPrincipal InvestigatorDurham VA Medical Center, Durham, NC
5 Previous Clinical Trials
14,596 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My treatment site may receive extra support.All participating sites will be trained on Foundational REP.
Research Study Groups:
This trial has the following groups:- Group 1: Foundational REP
- Group 2: Enhanced REP
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this medical experiment still available?
"Per the information on clinicaltrials.gov, this research project is no longer recruiting participants - with its original posting date of April 25th 2022 and most recent update being April 27th 2022. Despite that fact, there are still 25 other studies actively enrolling patients at present time."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger